Bolt Biotherapeutics (BOLT) IPO Opens 31% Higher

Today's IPO for Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) opened for trading at $26.10 after pricing 11,500,000 shares of common stock at a price to the public of $20.00 per share.

Morgan Stanley, SVB Leerink, Stifel and Guggenheim Securities are acting as joint bookrunners for the offering.

BOLT is a a clinical-stage immuno-oncology company

You May Also Be Interested In

• Viking Holdings (VIK) Announces 44M Share IPO at $21-$25/sh
• Tungray Technologies (TRSG) Prices 1.25M Share IPO at $4/sh
• Rubrik IPO: 5 key things to know